TipRanks
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Germany Market
137
Aldeyra Therapeutics
RESEARCH TOOLSreports

Aldeyra Therapeutics (137) Cash flow

0 Followers

Aldeyra Therapeutics Cash Flow

DE:137's free cash flow for Q2 2026 was $-4.61M. For the 2026 fiscal year, DE:137's free cash flow was decreased by $9.86M and operating cash flow was $-4.59M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -33.35M$ -43.21M$ -30.33M$ -56.64M$ -42.56M
Investing Cash Flow
$ 47.74M$ -44.92M$ 30.00M$ -29.95M$ -7.81K
Financing Cash Flow
$ 1.12M$ -171.42K$ -1.27M$ 1.22M$ 194.50M
End Cash Position
$ 70.04M$ 54.53M$ 142.82M$ 144.42M$ 229.79M
Free Cash Flow
$ -33.35M$ -43.21M$ -30.33M$ -56.65M$ -42.56M
Currency in USD

Aldeyra Therapeutics Cash Flow